96 related articles for article (PubMed ID: 2773181)
1. [The development of calcium metabolic disorders in patients in the terminal stage of chronic kidney failure receiving hemodialysis treatment].
Kalashnikov AIa; Kon'kova TA; Popovkin NN; Iarmolinskiĭ IS
Urol Nefrol (Mosk); 1989; (3):46-52. PubMed ID: 2773181
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. [The use of xidifon for the correction of phosphorus-calcium metabolism in patients in the terminal stage of chronic kidney failure who are on programmed hemodialysis].
Konstantinova OV; Ianenko EK; Danilkov AP; Pashkin IN
Urol Nefrol (Mosk); 1997; (3):23-5. PubMed ID: 9245050
[TBL] [Abstract][Full Text] [Related]
4. [Use of the equipment for hemodialysis in the diagnosis of calcium metabolism disorders in terminal chronic renal failure].
Ermakova IP; Novikov AI; Pronchenko IA; Sokolova TIu; Baeva LB; Ermolenko AE; Levitskiĭ ER
Med Tekh; 1991; (1):27-9. PubMed ID: 2038254
[TBL] [Abstract][Full Text] [Related]
5. [Changes of calcium-phosphorus metabolism in patients with chronic renal failure on hemodialysis treatment].
Pérez Ruilópez MA; Damiano Rivero A; Herrerías Echabe JM; Garrido Peralta M
Rev Iber Endocrinol; 1976; 23(138):535-55. PubMed ID: 1013577
[TBL] [Abstract][Full Text] [Related]
6. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
7. Is anemia of chronic renal failure related to secondary hyperparathyroidism?
Podjarny E; Rathaus M; Korzets Z; Blum M; Zevin D; Bernheim J
Arch Intern Med; 1981 Mar; 141(4):453-5. PubMed ID: 7212887
[TBL] [Abstract][Full Text] [Related]
8. Secondary hyperparathyroidism in chronic renal failure.
Malmaeus J
Scand J Urol Nephrol Suppl; 1983; 70():1-63. PubMed ID: 6351238
[TBL] [Abstract][Full Text] [Related]
9. Determinants of arterial compliance in patients treated by hemodialysis.
Level C; Lasseur C; Delmas Y; Cazin MC; Vendrely B; Chauveau P; Gosse P; Combe C
Clin Nephrol; 2001 Dec; 56(6):435-44. PubMed ID: 11770795
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of the early treatment of secondary hyperparathyroidism with calcitriol in hemodialysis patients.
Delmez JA; Kelber J; Norwood KY; Giles KS; Slatopolsky E
Clin Nephrol; 2000 Oct; 54(4):301-8. PubMed ID: 11076106
[TBL] [Abstract][Full Text] [Related]
11. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
12. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
13. [Osteocalcin in chronic hemodialysis patients as an additional parameter in the diagnosis of advanced secondary hyperparathyroidism].
Motz W
Acta Med Austriaca; 1989; 16(1):8-12. PubMed ID: 2785325
[TBL] [Abstract][Full Text] [Related]
14. Albumin-corrected or ionized calcium in renal failure? What to measure?
Gøransson LG; Skadberg Ø; Bergrem H
Nephrol Dial Transplant; 2005 Oct; 20(10):2126-9. PubMed ID: 16030044
[TBL] [Abstract][Full Text] [Related]
15. Secondary hyperparathyroidism in patients on maintenance hemodialysis.
Hida M
Tokai J Exp Clin Med; 1982 Nov; 7(6):665-70. PubMed ID: 7184198
[TBL] [Abstract][Full Text] [Related]
16. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
Lindberg J; Martin KJ; González EA; Acchiardo SR; Valdin JR; Soltanek C
Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662
[TBL] [Abstract][Full Text] [Related]
17. Clinical epidemiology of parathyroidectomy in hemodialysis patients: the USRDS waves 1, 3, and 4 study.
Slinin Y; Foley RN; Collins AJ
Hemodial Int; 2007 Jan; 11(1):62-71. PubMed ID: 17257358
[TBL] [Abstract][Full Text] [Related]
18. Secondary hyperparathyroidism in patients on maintenance hemodialysis: study of the N and C-terminal parathyroid hormones.
Hida M; Shimbo T; Nakamura K; Wakabayashi T; Saitoh H; Satoh T
Tokai J Exp Clin Med; 1983 Jul; 8(3):225-8. PubMed ID: 6670108
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of the parathyroid gland in patients with end-stage renal disease.
Albertucci M; Zielinski CM; Rothberg M; Sterpetti A; Klingman R; Ronk JF
Surg Gynecol Obstet; 1988 Jul; 167(1):49-52. PubMed ID: 3381185
[TBL] [Abstract][Full Text] [Related]
20. Ten years' experience in subtotal parathyroidectomy of hemodialysis patients.
Jovanovic DB; Pejanovic S; Vukovic L; Djukanovic L; Jankovic R; Kalezic N; Paunovic I; Zivaljevic V
Ren Fail; 2005; 27(1):19-24. PubMed ID: 15717630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
